PMID- 33688367 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20210312 IS - 1741-427X (Print) IS - 1741-4288 (Electronic) IS - 1741-427X (Linking) VI - 2021 DP - 2021 TI - Evaluation of Beneficial and Adverse Effects of a Diet Supplemented with Schisandrae Fructus Seed Ethanol Extract on Lipid and Glucose Metabolism in Normal and Hypercholesterolemic/Hyperglycemic Mice. PG - 8858962 LID - 10.1155/2021/8858962 [doi] LID - 8858962 AB - Schisandrae Fructus (SF), the fruit of Schisandra chinensis (Turcz.) Baillon, has been used for the treatment of liver injury and metabolism-related disorders in China. The objective of this study was to investigate the effects of supplementation with ethanol extract of SF seed (EtSF-S) on serum/hepatic lipid and glucose levels as well as fecal total cholesterol (TC) contents in mice fed a normal diet (ND) or high-fat/fructose diet (HFFD) containing 15% lard oil and 15% fructose. Female ICR mice (18-20 g in body weight) were fed with ND or HFFD for 3 months, and then EtSF-S was added to both chow diets at increasing concentrations of 1, 5, and 10% (w/w). Thirty days later, serum and hepatic lipids, including TC, triglyceride (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), and glucose, were measured. Dietary supplementation with EtSF-S reduced hepatic TC (36 and 18%) and TG levels (38 and 28%) and increased serum HDL/LDL ratio (16 and 26%) in both ND- and HFFD-fed mice, respectively. Moreover, supplementation with EtSF-S elevated serum HDL (31%) in HFFD-fed mice and reduced serum LDL (27%) in ND-fed mice. EtSF-S treatment reduced fat mass (40%) in ND-fed mice and increased fecal TC contents (33%) in HFFD-fed mice. EtSF-S supplementation decreased hepatic glucose contents (29%) in both ND- and HFFD-fed mice. However, diet supplemented with EtSF-S elevated serum TG levels (up to 123%) and hepatic size (28%), but more importantly, suppressed the body weight gain (approximately 130%) in mice fed with HFFD. These findings suggested that dietary supplementation with EtSF-S as natural herbal function food may be a useful strategy for the treatment of patients with fatty liver disease or overweight without a high intake of sugar and fat. CI - Copyright (c) 2021 Xiao-Yan Wang et al. FAU - Wang, Xiao-Yan AU - Wang XY AD - The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, China. FAU - Song, Xue-Lan AU - Song XL AD - School of Traditional Dai-Thai, West Yunnan University of Applied Sciences, Jinghong, China. FAU - Zhang, Yi AU - Zhang Y AD - School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China. FAU - Luo, Gan AU - Luo G AD - School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China. FAU - Tai, Hai-Chuan AU - Tai HC AD - School of Traditional Dai-Thai, West Yunnan University of Applied Sciences, Jinghong, China. FAU - Lin, Zhao-Heng AU - Lin ZH AD - School of Traditional Dai-Thai, West Yunnan University of Applied Sciences, Jinghong, China. FAU - Zhu, Pei-Li AU - Zhu PL AD - School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China. FAU - Sun, Nan AU - Sun N AD - School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China. FAU - Chu, Zhu-Sheng AU - Chu ZS AD - School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China. FAU - Yu, Zhi-Ling AU - Yu ZL AD - School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China. FAU - Pan, Si-Yuan AU - Pan SY AUID- ORCID: 0000-0002-4842-9629 AD - School of Traditional Dai-Thai, West Yunnan University of Applied Sciences, Jinghong, China. AD - School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China. FAU - Tang, Jin-Fa AU - Tang JF AUID- ORCID: 0000-0001-7786-0955 AD - The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, China. FAU - Ko, Kam-Ming AU - Ko KM AD - Division of Life Science, Hong Kong University of Science & Technology, Hong Kong, China. LA - eng PT - Journal Article DEP - 20210220 PL - United States TA - Evid Based Complement Alternat Med JT - Evidence-based complementary and alternative medicine : eCAM JID - 101215021 PMC - PMC7920717 COIS- The authors declare that they have no conflicts of interest. EDAT- 2021/03/11 06:00 MHDA- 2021/03/11 06:01 PMCR- 2021/02/20 CRDT- 2021/03/10 08:19 PHST- 2020/08/18 00:00 [received] PHST- 2020/12/01 00:00 [revised] PHST- 2021/01/21 00:00 [accepted] PHST- 2021/03/10 08:19 [entrez] PHST- 2021/03/11 06:00 [pubmed] PHST- 2021/03/11 06:01 [medline] PHST- 2021/02/20 00:00 [pmc-release] AID - 10.1155/2021/8858962 [doi] PST - epublish SO - Evid Based Complement Alternat Med. 2021 Feb 20;2021:8858962. doi: 10.1155/2021/8858962. eCollection 2021.